Business Standard

Alkem Laboratories Share Price

Know More
BSENSE

4,695.65-7.50 (-0.16%)

04:01 PM,24th Apr 2024

4,720.95 16.55 (0.35%)

03:53 PM,24th Apr 2024

BSE : 539523

NSE : ALKEM

Sector : Health care

ISIN Code : INE540L01014

  • BSE
  • NSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 24-Apr-2024 | 04:01 PM IST

Market Cap (₹ Cr)

56,137

Turnover (₹ Cr)

0.03

Volume (Shares)

677

Face Value

2

52-WK High

5,519.10

52-WK High Date

21-Feb-2024

52-WK Low

3,211.05

52-WK Low Date

22-May-2023

All Time High

5,519.10

All Time High Date

21-Feb-2024

All Time Low

1,175.00

All Time Low Date

02-May-2016

Alkem Laboratories Ltd

Headquartered in Mumbai India Alkem Laboratories Limited is a leading Indian pharmaceutical company with global operations. The company is engaged in the development manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics generic drugs active pharmaceutical ingredients (APIs) and nutraceuticals which it markets in India and international markets. With a portfolio of more than 800 brands in India Alkem is ranked the fifth largest pharmaceutical company in India in terms of domestic sales. The company also has presence in more than 40 international markets with the United States being its key focus market. Alkem Laboratories Ltd was incorporated...
Read More

Alkem Lab Announcement

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Alkem Laboratories Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L00305MH1973PLC174201</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>AA+</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>CRISIL LTD.</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Manish Narang <br/> Designation: President Legal Company Secretary and Compliance Officer <br/> EmailId: manishnarang@alkem.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Nitin Agrawal <br/> Designation: President Finance and Chief Financial Officer <br/> EmailId: nitin.agrawal@alkem.com</div> </div> <div> <br/> Date: 23/04/2024<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>

View More

Alkem Laboratories Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

56,439

EPS - TTM (₹) [S]

143.82

P/E Ratio (X) [S]

5.56

Face Value (₹) 2
Latest Dividend (%)1,750.00
Latest Dividend Date 16-Feb-2024
Dividend Yield (%) 1.06
Book Value Share (₹) [S]848.50
P/B Ratio (₹) [S]5.56

Funds Owing this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
DSP Midcap Fund (G) 646.17 13,07,508 4.05
DSP Midcap Fund (IDCW) 646.17 13,07,508 4.05
DSP Midcap Fund - Direct (IDCW) 646.17 13,07,508 4.05
DSP Midcap Fund - Direct (G) 646.17 13,07,508 4.05
AXIS Midcap Fund (G) 401.86 8,13,160 1.57
AXIS Midcap Fund (IDCW) 401.86 8,13,160 1.57
AXIS Midcap Fund - Direct (G) 401.86 8,13,160 1.57
AXIS Midcap Fund - Direct (IDCW) 401.86 8,13,160 1.57
Nippon India Growth Fund - (G) 390.42 7,90,000 1.57
Nippon India Growth Fund - (IDCW) 390.42 7,90,000 1.57

Load more

Research Reports

Date Broker Action Prices(₹) Report
10-Aug-2022Choice Research Neutral 3,108

Stock Strength

Today's Low/High

4,691.00

4,759.65

Week Low/High

4,567.05

4,792.00

Month Low/High

4,567.05

5,095.00

Year Low/High

3,186.30

5,520.00

All time Low/High

1,175.00

5,520.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-0.28%-0.28%1.251.15%
1 Month-1.51%-1.44%1.401.38%
3 Month-5.52%-5.57%3.934.42%
6 Month33.67%33.59%14.3716.18%
1 Year37.59%37.69%22.9726.26%
3 Year70.00%69.91%54.2556.21%

Company Info

Company Information

Executive Chairman : Basudeo N Singh

Managing Director : SANDEEP SINGH

Executive Director : Mritunjay Kumar Singh

Non-Exec. & Independent Dir. : A K Purwar

Non-Exec. & Independent Dir. : SANGEETA KAPILJIT SINGH

Non-Exec. & Independent Dir. : SUDHA RAVI

Company Sec. & Compli. Officer : Manish Narang

Non-Exec. & Independent Dir. : Dheeraj Sharma

Non-Exec. & Independent Dir. : Narendra Aneja

Executive Director : SARVESH SINGH

Executive Director : Madhurima Singh

Independent Director : Sujjain Talwar

Executive Director : Srinivas Singh

Registered Office: Alkem House SenapatiBapat Marg, Lower Parel,Mumbai,Maharashtra-400013 Ph: 91-22-39829999

Email:investors@alkem.com ; contact@alkem.com

URL:http://www.alkemlabs.com